TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biotechst Lund AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
55
|
75 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
-9
|
7 | |
| EBITDA |
-9
|
7 | |
| Total assets |
29
|
47 | |
| Current assets |
29
|
47 | |
| Current liabilities |
9
|
16 | |
| Equity capital |
20
|
31 | |
| - share capital |
8
|
9 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
69.0%
|
66.0% | |
| Turnover per employee |
55
|
75 | |
| Profit as a percentage of turnover |
-16.4%
|
9.3% | |
| Return on assets (ROA) |
-31.0%
|
14.9% | |
| Current ratio |
322.2%
|
293.8% | |
| Return on equity (ROE) |
-45.0%
|
22.6% | |
| Change turnover |
-13
|
10 | |
| Change turnover % |
10%
|
-19%
|
15% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.